GSK Investigational Site

Thornhill, Ontario L4J 8L7

0 studies enrolling now · 8 studies all time

What they study most

Atherosclerosis, Diabetes Mellitus, Type 2, Gastroparesis, Neuralgia, Postherpetic

Studies at this site

• Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis — Completed
• Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus — Completed
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed
• Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed
• Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early
• Study In People With Type 2 Diabetes — Completed
• A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN) — Completed